Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study [PDF]
, 2023 Lauren K. Park +17 more
openalex +1 more source
Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
Linchuang shenzangbing zazhi, 2021 As one of the most common microvascular complications of diabetes mellitus, diabetic nephropathy（DN）is a common cause of end-stage renal disease（ESRD）.Sodium-glucose cotransporter 2（SGLT-2）inhibitor, a new type of hypoglycemic agent, may effectively ...
Kong Ling-li +4 more
doaj
A Systemic Receptor Network Triggered by Human cytomegalovirus Entry [PDF]
, 2010 Virus entry is a multistep process that triggers a variety of cellular pathways interconnecting into a complex network, yet the molecular complexity of this network remains largely unsolved.
Li, Hong, Ren, Li, Wang, Anyou
core +4 more sources
Proteomics: in pursuit of effective traumatic brain injury therapeutics [PDF]
, 2015 Effective traumatic brain injury (TBI) therapeutics remain stubbornly elusive. Efforts in the field have been challenged by the heterogeneity of clinical TBI, with greater complexity among underlying molecular phenotypes than initially conceived.
Ahmed F +64 more
core +2 more sources
Сучасні медичні технологіїThe number of patients with chronic heart failure syndrome is steadily increasing worldwide and Ukraine is not an exception. About 50 % of patients with heart failure have preserved ejection fraction of left ventricle.
M. Yu. Kolesnyk, Ya. Yu. Maistrovych
doaj +1 more source
Euglycemic diabetic ketoacidosis development in a patient with type 2 diabetes receiving a sodium-glucose cotransporter-2 inhibitor and a carbohydrate-restricted diet [PDF]
, 2023 Gwanpyo Koh +3 more
openalex +1 more source
Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors
MedisurHeart failure is a chronic disease that affects millions of people worldwide and is a leading cause of death. Sodium-glucose cotransporter type 2 inhibitors are a new class of drugs that have demonstrated cardiovascular benefits in patients with type 2 ...
Riber Fabián Donoso Noroña +2 more
doaj
Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options
Therapeutics and Clinical Risk Management, 2015 Susan Cornell Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, USA Abstract: Diabetes is a complex and progressive disease that has a major societal and economic impact.
Cornell S
doaj